• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
DXB

DIMERIX LIMITED

7.69% ! 56.0¢
Market Cap $336.2M  !

Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The... Dimerix Limited is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on developing lives of patients with inflammatory diseases, including both kidney and respiratory diseases. It develops and commercializes patient preferred pharmaceutical products for global markets using its receptor technology to identify and develop drugs in areas with an unmet need. The Company is focused on developing its Phase III product candidate DMX-200 (QYTOVRA), for Focal Segmental Glomerulosclerosis (FSGS) kidney disease and is also developing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD). Its Receptor Heteromer Investigation Technology (Receptor-HIT) is a scalable and globally applicable technology platform enabling the understanding of receptor interactions to rapidly screen and identify new drug opportunities. Its products target multiple global territories, with the initial focus predominantly on the United States and European markets. More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
DXB
Broker Reports
2 3 4
08:40 223 58K
08:40 Last post  RYNZN Comments Created with Sketch.  223  Views Created with Sketch.  58K 
DXB
DXB Chart
49 50 51
07/12/25 3.0K 1.2M
07/12/25 Last post  CloseTheMarkets Comments Created with Sketch.  3.0K  Views Created with Sketch.  1.2M 
DXB 06/12/25 104 24K
06/12/25 Last post  Ziggymux Comments Created with Sketch.  104  Views Created with Sketch.  24K 
DXB
Industry News
26/11/25 0 371
26/11/25 Last post  Gorey29 Comments Created with Sketch.  0  Views Created with Sketch.  371 
DXB 26/11/25 187 43K
26/11/25 Last post  vintage Comments Created with Sketch.  187  Views Created with Sketch.  43K 
DXB 19/11/25 5 2.2K
19/11/25 Last post  Scottyhilux Comments Created with Sketch.  5  Views Created with Sketch.  2.2K 
DXB 18/11/25 0 330
18/11/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  330 
DXB 14/11/25 40 18K
14/11/25 Last post  betheball Comments Created with Sketch.  40  Views Created with Sketch.  18K 

See All Discussions arrow Created with Sketch.

Timeline

Successful Completion of Planned IDMC Review
19 Nov 09:05
 
Results of AGM
18 Nov 16:58
 
Chair Address and AGM Presentation
18 Nov 12:58
 
Quarterly Appendix 4C and Activities Report
29 Oct 08:35
 
Cleansing Notice
22 Oct 16:20
 
Application for quotation of securities - DXB
22 Oct 16:13
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
56.0¢
Change
0.040(7.69%)
Mkt cap ! $336.2M
Open High Low Volume
55.0¢ 58.0¢ 54.0¢ 3.198M

Buyers (Bids)

Vol. Price($)
2740 55.5¢
 

Sellers (Offers)

Price($) Vol.
56.0¢ 24004
Last trade - 16.10pm 05/12/2025 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.